Casana, the company behind the Heart Seat, is now pursuing approvals for additional indications. 

The device, available in much of Europe since 2020, features Medtronic's new meal detection technology.

The study's findings suggest that AI can help clinicians provide more personalized care than ever before. 

The link between NSAIDs such as ibuprofen and heart failure was especially strong among patients 80 years old and older. For patients 65 years old and younger, on the other hand, no such link was identified. 

The news comes after Abbott had to recall more than 4.2 million older glucose monitoring systems due to issues with batteries overheating. 

Clopidogrel is especially effective at limiting major adverse cardiovascular events among PCI patients with diabetes, researchers found. 

While the U.S. Preventive Services Task Force still uses weight to guide its screening recommendations, new research suggests focusing on age alone provides more value. 

Abbott previously issued a voluntary medical device correction about this problem, but no recall had been announced at that time. The recall includes devices distributed from November 2017 to February 2023.